NYU Langone Among First Centers to Enroll Patients in US Clinical Trial for COVID-19 mRNA Vaccine,

The first U.S. patients have been dosed in a clinical trial testing whether four experimental mRNA vaccine candidates can prevent infection with the virus that causes COVID-19 disease.   Pfizer Inc., The first U.S. patients have been dosed in a clinical trial testing whether four experimental mRNA vaccine candidates can prevent infection with the virus that causes COVID-19 disease.   Pfizer Inc., Read More

Scroll to Top